neurocrine biosciences News
Most Popular neurocrine biosciences Story
Insomnia market attracts drug developers
The market for insomnia drugs in the U.S. is growing at a whopping 29 percent per year, hitting $4.6 billion in 2006 and attracting the attention of a wide range of drug developers. More than a... Read more...
Latest Headlines
- May 6, 2009
- October 8, 2007
- November 3, 2006
- November 2, 2006
- September 19, 2006
- September 4, 2006
- August 7, 2006
- July 20, 2006
- May 15, 2006
- March 7, 2006
- November 1, 2005
- June 28, 2005
Paid Research Reports
- Stakeholder Opinions: Vaccines in Emerging Markets (Asia) - Opportunities in China, India, South Korea and Taiwan
- Big Pharma Performance Before, During and Beyond the Global Recession
- Optimizing Lifecycle Management: Maximizing commercial lifespan through label expansion and combination products
- The CRO Market Outlook: Emerging markets, leading players and future trends
- Pharmaceutical Sales Force Effectiveness Strategies
- Commercial Insight: Influenza Vaccines and Antivirals - The pandemic's long-term impact
